Breakthrough T1D has shifted this opportunity to focus exclusively on the Industry Discovery & Development Partnership (IDDP) program, meaning academic and nonprofit institutions are no longer eligible. If you are applying as a for-profit entity, you can now submit Letters of Intent on a rolling basis year-round instead of adhering to the previous fall deadlines. Additionally, there is no longer a strict $3 million funding cap, but you must secure a 1:1 company match and contact program staff before applying.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs and proposals accepted year-round)
Funding Amounts: No strict maximum; awards typically require company matching funds and are negotiated based on project scope and need.
Summary: Supports for-profit companies developing therapies, devices, or technologies for type 1 diabetes that align with Breakthrough T1D priorities.
Key Information: Requires 1:1 company matching funds; applicants must contact Breakthrough T1D before submitting an LOI.